Oragenics (OGEN) Stock Chart & Stock Price History $1.31 -0.08 (-5.76%) As of 01:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Oragenics Stock Price Performance The Oragenics (OGEN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 88.63%, with a year-to-date return of -88.09%. In the past month, the stock has increased 16.30%, reflecting recent market activity. As of the latest close, Oragenics traded at $1.39 with a market cap of $5.74 million and volume of 88,030 shares. Five years ago, the stock traded at a split-adjusted price of $991.62, representing a 99.87% decrease over that period. At the time, it had a market cap of $33.61 million and a volume of 1,389 shares. Receive OGEN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+0.76%1 Month Performance+16.30%3 Month Performance-9.59%Year-To-Date Performance-88.09%1 Year Performance-88.63%5 Year Performance-99.87% OGEN Stock Chart for Friday, October, 10, 2025 OGEN Chart by TradingView Oragenics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/09/2025$1.39$1.39$1.41$1.3788,030 shs$5.74 million10/08/2025$1.37$1.39+1.46%$1.45$1.33405,824 shs$5.74 million10/07/2025$1.30$1.37+5.38%$1.39$1.271.93 million shs$5.66 million10/06/2025$1.31$1.30-0.76%$1.32$1.26119,860 shs$5.37 million10/03/2025$1.35$1.31-2.96%$1.37$1.26195,490 shs$5.41 million10/02/2025$1.42$1.35-4.93%$1.42$1.33104,286 shs$5.57 million10/01/2025$1.31$1.42+8.40%$1.43$1.30172,661 shs$5.86 million09/30/2025$1.34$1.31-2.24%$1.33$1.3054,888 shs$5.41 million09/29/2025$1.27$1.34+5.51%$1.34$1.26111,250 shs$5.53 million09/26/2025$1.28$1.27-0.78%$1.36$1.2474,186 shs$5.24 million Get the Latest News and Ratings for OGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter. 09/25/2025$1.30$1.28-1.54%$1.31$1.2586,274 shs$5.28 million09/24/2025$1.35$1.30-3.70%$1.34$1.26114,220 shs$5.37 million09/23/2025$1.34$1.35+0.75%$1.44$1.32403,787 shs$5.57 million09/22/2025$1.19$1.34+12.61%$1.34$1.16234,137 shs$5.53 million09/19/2025$1.21$1.19-1.65%$1.28$1.1999,135 shs$4.91 million09/18/2025$1.26$1.21-3.97%$1.29$1.21135,721 shs$4.99 million09/17/2025$1.30$1.26-3.08%$1.32$1.2596,112 shs$5.20 million09/16/2025$1.27$1.30+2.36%$1.31$1.22145,153 shs$5.37 million09/15/2025$1.21$1.27+4.96%$1.34$1.21320,928 shs$5.24 million09/12/2025$1.15$1.21+5.22%$1.25$1.10235,769 shs$4.99 million09/11/2025$1.14$1.15+1.32%$1.16$1.1075,452 shs$4.75 million09/10/2025$1.17$1.14-2.58%$1.17$1.1275,651 shs$4.68 million09/09/2025$1.17$1.17-0.43%$1.17$1.1575,819 shs$4.81 million Related Companies Citius Pharmaceuticals Stock Chart NanoViricides Stock Chart Cingulate Stock Chart Synaptogenix Stock Chart CytoMed Therapeutics Stock Chart Lixte Biotechnology Stock Chart FibroBiologics Stock Chart Clearside Biomedical Stock Chart Leap Therapeutics Stock Chart Rallybio Stock Chart Receive OGEN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:OGEN) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oragenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
